Revenue
160 thousand USD
2027 Q2 · USD
Exact inputs and evidence
- Revenue: 160038 USD Source
Market value is not computed: no listed ticker is recorded for this company.
Annual consolidated revenue for 2026: about USD 77, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2025, was about USD 33.56K.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-20; this is not a statement that none were filed.
These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.
160 thousand USD
2027 Q2 · USD
21.99%
2027 Q2 · %
41.5 thousand USD
2027 Q2 · USD
149 USD
66599350 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
160 thousand USD
2025-08-01 – 2026-07-31
-47.5 thousand USD
2025-08-01 – 2026-07-31
-49 thousand USD
2025-08-01 – 2026-07-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-28.
Financial data available through: 2026-01-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 33,563
–
Current period
USD 77
–
77 − 33563 = -33486 USD
33563 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source77 USD · 2025-02-01 – 2026-01-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 27,436
–
Current period
−USD 93,398
–
-93398 − -27436 = -65962 USD
-27436 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source-93398 USD · 2025-02-01 – 2026-01-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 20,224
–
Current period
−USD 103,071
–
-103071 − -20224 = -82847 USD
-20224 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source-103071 USD · 2025-02-01 – 2026-01-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2021-02-01 – 2022-01-31 | 24500 | 23758 Derived | 742 | 1484 Derived | -742 | Unavailable | Source
|
| 2023 2022-02-01 – 2023-01-31 | 243060 | 257668 Derived | -14608 | 0 Derived | -14608 | -20166 Derived | Source
|
| 2024 2023-02-01 – 2024-01-31 | 30000 | 58134 Derived | -28134 | -6010 Derived | -22124 | -13338 Derived | Source
|
| 2025 2024-02-01 – 2025-01-31 | 33563 | 60999 Derived | -27436 | 0 Derived | -27436 | -20224 Derived | Source
|
| 2026 2025-02-01 – 2026-01-31 | 77 | 93475 Derived | -93398 | 0 Derived | -93398 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 24500 |
|
| 2023 | Revenue | 243060 |
|
| 2024 | Revenue | 30000 |
|
| 2025 | Revenue | 33563 |
|
| 2026 | Revenue | 77 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 892.1% |
|
| 2024 | Year over year | -87.7% |
|
| 2025 | Year over year | 11.9% |
|
| 2026 | Year over year | -99.8% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | 3% |
|
| 2023 | Operating margin | -6% |
|
| 2024 | Operating margin | -93.8% |
|
| 2025 | Operating margin | -81.7% |
|
| 2026 | Operating margin | -121,296.1% |
|
| 2022 | Net margin | -3% |
|
| 2023 | Net margin | -6% |
|
| 2024 | Net margin | -73.7% |
|
| 2025 | Net margin | -81.7% |
|
| 2026 | Net margin | -121,296.1% |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | -8.3% |
|
| 2024 | Free cash flow margin | -44.5% |
|
| 2025 | Free cash flow margin | -60.3% |
|
| 2026 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | -8653 |
|
| 2023 | Operating cash flow | -17813 |
|
| 2024 | Operating cash flow | -13338 |
|
| 2025 | Operating cash flow | -20224 |
|
| 2026 | Operating cash flow | -103071 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | -20166 |
|
| 2024 | Free cash flow | -13338 |
|
| 2025 | Free cash flow | -20224 |
|
| 2026 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Liabilities / assets | 30% |
|
| 2023 | Liabilities / assets | 32.8% |
|
| 2024 | Liabilities / assets | 298.7% |
|
| 2025 | Liabilities / assets | 747.7% |
|
| 2026 | Liabilities / assets | 2,523.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Current assets / current liabilities | 3.02× |
|
| 2023 | Current assets / current liabilities | 2.42× |
|
| 2024 | Current assets / current liabilities | 0.11× |
|
| 2025 | Current assets / current liabilities | 0.06× |
|
| 2026 | Current assets / current liabilities | 0.02× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2021-02-01 – 2022-01-31 | −USD 742 Exact valueExact value: -742 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8,653 Exact valueExact value: -8653 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-02-01 – 2023-01-31 | −USD 14,608 Exact valueExact value: -14608 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17,813 Exact valueExact value: -17813 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2,353 Exact valueExact value: 2353 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20,166 Calculation and evidence-17813 − 2353 USD Exact free cash flow: -20166 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-02-01 – 2024-01-31 | −USD 22,124 Exact valueExact value: -22124 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13,338 Exact valueExact value: -13338 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13,338 Calculation and evidence-13338 − 0 USD Exact free cash flow: -13338 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-02-01 – 2025-01-31 | −USD 27,436 Exact valueExact value: -27436 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20,224 Exact valueExact value: -20224 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20,224 Calculation and evidence-20224 − 0 USD Exact free cash flow: -20224 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-02-01 – 2026-01-31 | −USD 93,398 Exact valueExact value: -93398 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 103,071 Exact valueExact value: -103071 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
25 filings · 980 latest values · 980 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001848672, 1848672, edgar:1848672
Also known as GLIDELOGIC CORP, GLIDELOGIC CORP., Glidelogic Corp.